Cite
APA Citation
Moebius, H. J., Bernick, C. B., Winner, P., Maalouf, J., Ooi, K., Dickson, S. P., Hendrix, S. B., Church, K., & Olichney, J. M. (n.d.). aCT‐AD: Fosgonimeton in mild‐to‐moderate Alzheimer's disease – first results of a randomized, placebo‐controlled, 26‐week Phase 2 proof‐of‐concept trial. Alzheimer's & dementia, 18, n/a. http://access.bl.uk/ark:/81055/vdc_100173096453.0x00001d